Literature DB >> 35118804

Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2.

Rachel Pass1,2, Niels Haan1, Trevor Humby3, Lawrence S Wilkinson1,3, Jeremy Hall1,4, Kerrie L Thomas1,5.   

Abstract

Mutations affecting DLG2 are emerging as a genetic risk factor associated with neurodevelopmental psychiatric disorders including schizophrenia, autism spectrum disorder, and bipolar disorder. Discs large homolog 2 (DLG2) is a member of the membrane-associated guanylate kinase protein superfamily of scaffold proteins, a component of the post-synaptic density in excitatory neurons and regulator of synaptic function and plasticity. It remains an important question whether and how haploinsuffiency of DLG2 contributes to impairments in basic behavioural and cognitive functions that may underlie symptomatic domains in patients that cross diagnostic boundaries. Using a heterozygous Dlg2 mouse model we examined the impact of reduced Dlg2 expression on functions commonly impaired in neurodevelopmental psychiatric disorders including motor co-ordination and learning, pre-pulse inhibition and habituation to novel stimuli. The heterozygous Dlg2 mice exhibited behavioural impairments in long-term motor learning and long-term habituation to a novel context, but not motor co-ordination, initial responses to a novel context, PPI of acoustic startle or anxiety. We additionally showed evidence for the reduced regulation of the synaptic plasticity-associated protein cFos in the motor cortex during motor learning. The sensitivity of selective behavioural and cognitive functions, particularly those dependent on synaptic plasticity, to reduced expression of DLG2 give further credence for DLG2 playing a critical role in specific brain functions but also a mechanistic understanding of symptom expression shared across psychiatric disorders.
© 2022 The Authors. Genes, Brain and Behavior published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.

Entities:  

Keywords:  PSD93; autism spectrum disorder; bipolar disorder; habituation; learning; psychosis; schizophrenia

Mesh:

Substances:

Year:  2022        PMID: 35118804      PMCID: PMC9393930          DOI: 10.1111/gbb.12799

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.708


INTRODUCTION

Schizophrenia (SZ), autism spectrum disorder (ASD), and bipolar disorder (BD) are often comorbid neurodevelopmental psychiatric disorders, , with overlapping symptoms, including cognitive, neurobehavioural and motor dysfunction. , , There is also a substantial portion of shared genetic risk, , , concordant with the correlation between functional disabilities and risk genes associated with developmental disorders. , Genetic analysis approaches, including genome wide association studies, studies of common variants as well as copy number variant (CNV) analysis, and exome sequencing for rarer but more penetrant mutations, combined with subsequent gene set enrichment analysis have been important for identifying the biological pathways underlying disorder pathophysiology and common targets for clinical interventions. This approach has uncovered an enrichment of genes involved in synaptic plasticity and the post‐synaptic density (PSD) in SZ. , , , , , , Convergence of mutations in genes important for synaptic formation, plasticity, and elimination have also been found in ASD, , , , , with meta‐analyses identifying postsynaptic complexes as one of three functionally interconnected pathways associated with ASD risk genes. , Discs large homolog 2 (DLG2, also known as post‐synaptic density protein‐93 [PSD‐93] and chapsyn‐110), is part of the membrane associated guanylate kinase (MAGUK) protein superfamily of scaffold proteins and is enriched at the PSD. MAGUKs primarily bind and stabilise proteins at synapses, and regulate the synaptic localization of glutamate receptors, key for synaptic transmission and synaptic plasticity. Both de novo CNVs and SNVs implicate DLG2 in increasing risk of SZ, , , , , ASD, , , and potentially BD. Mutations in DLG2 affecting its function and/or expression are plausibly related to the impairments of learning and memory underlying in the cognitive deficits seen in SZ, as well as altered synaptic plasticity linked to abnormal sociability and motor deficits reminiscent of ASD. , , , , Indeed, homozygous knockout mice (Dlg2 ) showed no impairment in simple forms of learning, but showed deficits in complex learning, cognitive flexibility and attention comparable to similar deficits in humans carrying mutations disrupting the coding region of DLG2. Furthermore, Dlg2 mice displayed abnormal social behaviours, , increased repetitive behaviours and hypoactivity in response to novelty, as well as defective long‐term potentiation (LTP) and aberrant excitatory synaptic transmission in the dorsal striatum. Significantly, the functions of Dlg2 and other members of the Dlg family are dissociable both at the behavioural and synaptic levels. , , , Most genetic lesions observed in humans are deletions within or of DLG2 , , , , and are heterozygous. , Little attention has been paid to investigating behavioural phenotypes associated with heterozygous Dlg2 models, arguably more translationally relevant than homozygous knockouts. Winkler et al. identified a Dlg2 dose‐dependent impairment of motor learning in mice. There has been no systematic investigation of reduced Dlg2 gene dosage on potentially core endophenotypes associated with SZ, ASD, BD, and other neuropsychiatric disorders including motor function, pre‐pulse inhibition (PPI) of startle responses and habituation to a novel stimulus. , , , , , , , , , In this study we investigated motor co‐ordination and motor learning, habituation to a novel context, PPI of the acoustic startle response (ASR) and anxiety in heterozygous Dlg2 adult male mice. Using cFos levels as a proxy marker for synaptic activity and plasticity, we also tested the hypothesis that in the heterozygous Dlg2 mice impaired behavioural function would be correlated with reduced activity‐dependent cFos activation.

METHODS

Animals

All procedures were conducted in accordance with local ethical guidelines and Animals (Scientific Procedures) Act (ASPA) (1986) under UK Home Office project licence PPL 30/3135. Dlg2 tm1a(EUCOMM)Wtsi mice (MGI:4842622, frame shift deletion targeting exon 14, encoding the SH3 domain common to DLG2 variants, hereafter Dlg2 or HET) were maintained heterozygously on a C57/BL6J background. Genotyping was conducted in house (Data S1). Dlg2 and WT controls were housed in mixed‐genotype standard cages with ≤5 littermates. Mice were maintained on a 12:12 hour light/dark cycle (light phase 8 a.m.–8 p.m.) with ad libtum access to standard food (RM3 E, Special Services Diet, Lillico, UK) and water. Cages were lined with wood shavings, and cardboard tubes and wooden sticks provided environmental enrichment. Holding rooms were maintained at 45%–60% humidity and 19–22°C.

Behavioural analysis

Data from three separate cohorts male of mice is presented in this manuscript, with Cohort 1 and Cohort 2 undergoing more than one behavioural test (Table S1). At start of testing mice were 8–12 weeks of age. All tasks were completed prior to lights off. All mice were habituated to the experimenter for 1 week before testing, and to procedural rooms for 5 min before training and testing.

Motor learning and performance

Two‐day (2d) rotarod motor learning and motor performance task. Mice were habituated to the experimental room for 5 min prior to the first trial. Each mouse received 5‐min trials on the rotarod (3 cm drum separated by flanges into 5 × 5.7 cm individual lanes, fall height 16 cm, 47,600, Ugo Basile, Italy). Motor training comprised of 5 trials across 2 days (Day 1, two trials, Day 2, three trials) during which the rotarod was accelerated incrementally from 5–50 rpm over 5 min. Animals were returned to home cages in the testing room between trials. Following completion of a trial for the whole cohort (approx. ITI 30 mins) the next trial was started. Starting on Day 3, to assess motor performance, mice then completed two 5‐min trials at a fixed speed (5–45 rpm in 5 rpm increments) over 5 days, with an inter‐trial interval of 20–30 min during which the mice were returned to their home cage in the test room. The mean latency to fall for two trials per speed was calculated. Three day (3d) rotarod motor learning task. Mice were habituated to the experimental room for 5 min prior to the first trial. Each mouse received 7 trials a day for 3 consecutive days. Each trial comprised of the rotarod accelerating incrementally from 4–40 rpm over 5 min, with an inter‐trial interval of 5 min during which the mice were returned to their home cage in the testing room. For the assessment of cortical activity using cFos IHC, experimental mice were trained on the accelerating rotarod under the same conditions. However, mice were single caged in their housing (not test) room for 1.5 h after the second trial on Day 1. Control mice were singled caged in the holding room for 1.5 h. In all tasks, mice were placed on the rod facing away from the experimenter. Rotarod training order was counterbalanced for genotype. Latency to fall (s), defined as the first fall from the rod or 1 full rotation on the rod, was measured for each mouse per trial. Consolidation of motor learning was analysed by comparing latency to fall between for the last trial on Day 1 (D1T7) to the first trial on Day 2 (D2T1), = latency to fall(s) (D2T1/(D2T1 + D1T7).

Acoustic startle and pre‐pulse inhibition

ASR and PPI of startle response was monitored using a SR‐Lab™ Startle Response System (San Diego Instruments, USA). Mice were placed in a Perspex tube (internal diameter 35 mm) mounted to a Perspex plinth containing a piezoelectric pressure‐sensitive accelerometer sensor. All data are reported as the weight adjusted average response amplitude (v avg) and the contribution of body weight to the startle response was accounted for using Kleiber's 0.75 mass exponent. A session began with a 5‐min presentation of scrambled white noise at background intensity (70 dB) to habituate the animals to the apparatus followed by 3 blocks of acoustic stimuli (pulses). The startle amplitude was 120 dB for block 1, 105 dB for block 2 and a range (80‐120 dB) in block 3. Pulse alone trials consisted of a 40 ms startle stimulus whilst pre‐pulse trials consisted of a 20 ms pre‐pulse at 4, 8 or 16 dB above background followed by a 40 ms startle stimulus (120 or 105 dB) 70 ms after the pre‐pulse. Blocks 1 and 2 began with 6 pulse alone trials (either 120 dB or 105 dB) followed by pseudorandom stimuli (pulse alone, pre‐pulse or no stimulus) every 15 s. In block 3 varying pulse alone stimuli (80–120 dB) were presented 3 times in a pseudorandom manner. Whole body startle responses were recorded as average startle during the 15 s window after pulse onset. No stimulus trials separated the blocks and ended the session. The startle response (startle amplitude) to the first three pulses at 105 and 120 dB were averaged and analysed as an index of emotional reactivity before appreciable habituation. To measure habituation of the startle response, responses to the first five pulse‐alone trials at each intensity were measured. For each animal the absolute PPI unconfounded by the initial startle response was calculated as the percentage reduction in startle amplitude in pre‐pulse (PPI) compared to pulse alone trials (105 dB and 120 dB). [%PPI = 100 × (ASRstartle pulse alone − ASRprepulse + startle pulse)/ASRstartle pulse alone].

Locomotor activity and habituation

The locomotor activity of individual mice was conducted in clear Perspex activity boxes (CeNeS Cognition, Cambridge, UK, 21 cm × 36 cm × 20 cm; 2 IR beams 3 cm from box end, 1 cm from box floor) in the dark. For each mouse, individual beam breaks were recorded (using a custom BBC BASIC V6 programme with additional ARACHNID interfacing, Campden Instruments, Loughborough, UK) in 5 min bins over a 2 h session for 5 consecutive days. Mice were assigned an activity box for the duration of experiment. Twelve mice were run concurrently and the order/time of testing was conserved across days. Each batch of 12 mice was counterbalanced for genotype. The total number of beam breaks per day was recorded and the total number of beam breaks in the first 6 bins (30 min quartile, Q1–Q4) each day was calculated to measure between‐session and within‐session activity, respectively. Changes in between‐session activity = beam breaks (Day 5/[Day1 + Day 5]).

RNA extraction and RT‐qPCR

Mice (12 WT, 12 HET) were culled via cervical dislocation and the pre‐frontal cortex (PFC), hippocampus and cerebellum dissected and flash frozen and samples stored at −80°C until use. RNA from tissue samples was isolated using QIAGEN RNeasy kits and DNase treated with an Ambion TURBO DNA‐free™ Kit (ThermoFisher Scientific, Delaware, USA). cDNA synthesis from 1.5 ng/μl RNA was performed using RNA to cDNA EcoDry Premix (Random Hexamers) (TaKaRa Europe SAS, Saint‐Germain‐en‐Laye, France). cDNA was diluted to achieve a 1:15 dilution and then stored at −20°C prior to qPCR. qPCR was conducted with the SensiMix SYBR® No‐ROX Kit (Meridian Bioscience, Cincinnati USA) on an StepOne Plus Applied Biosystems Real‐Time PCR instrument (ThermoFisher Scientific, Delaware, USA; 1 cycle 95°C, 10 mins; 45 cycles of 95°C, 15 s; 60°C, 1 min). Potential compensatory changes in the expression of other Dlgs genes have been found in homozygous Dlg2 mice previously, so mRNA expression of Dlg1, Dlg3 and Dlg4 was measured in addition to Dlg2. Hprt and Gapdh acted as housekeeping genes. Primers were designed using NCBI Primer‐BLAST (5′‐3′: Dlg1 ‐CGAAGAACAGTCTGGGCCTT (forward), GGGGATCTGTGTCAGTGTGG (reverse); Dlg2 ‐ TGCCTGGCTGGAGTTTACAG (forward), TTTTACAATGGGGCCTCCGC (reverse); Dlg3 ‐ GAGCCAGTGACACGACAAGA (forward), GCGGGAACTCAGAGATGAGG (reverse); Dlg4 ‐ GGGCCTAAAGGACTTGGCTT (forward), TGACATCCTCTAGCCCCACA (reverse); Gapdh ‐ GAACATCATCCCTGCATCCA (forward), CCAGTGAGCTTCCCGTTCA (reverse); UBC ‐ CCAGTGTTACCACCAAGAAGGT (forward), CCATCACACCCAAGAACAAGC (reverse) and commercially synthesised (Merck Life Science UK Ltd, Gillingham, Dorset, UK). All qPCR samples were run in triplicate and the outcome was calculated using the 2−ΔΔCt method.

cFos immunohistochemistry

Mice were transcardially perfused under terminal anaesthesia (0.1 ml 200 mg/ml Euthatal, Duggan Veterinary Supplies Ltd, Tipperary, Ireland) using PBS and 4% PFA and the brains removed. Following 24 h post‐fixation in 4% PFA, the brains were cryopreserved in 30% sucrose in PBS at 4°C then embedded in Tissue Plus O.C.T. compound (ThermoFisher Scientific, UK) before storage at −80°C. One in ten coronal sections (40 μm) were cut and collected using a Lecia CM1900 cyrostat (Leica Biosystems, UK) spanning the emergence of cortical M1 (approx. Bregma +2.3 to +2.2 mm) and stored in 1X PBS at 4°C. Sections were blocked in 1% Triton‐X, 500 μl PBS (PBST) containing 3% normal donkey serum (S30‐100ML, Millipore, Hertfordshire, UK) at room temperature (RT) with agitation for 2 h. Rabbit anti‐cFos (ABE457, 1:5000, Merck Millipore, Hertfordshire, UK) was diluted in 500 μl 0.1% PBST with 0.2% normal donkey serum (v/v) and incubated overnight with agitation at 4°C. Following washes, Invitrogen Alexa Fluor Plus 488® goat anti‐rabbit secondary antibody (A32731 ThermoFisher Scientific, UK) was diluted (1:1000) in 500 μl 0.1% PBST with 0.2% normal donkey serum (S30‐100ML, Merck Millipore, Hertfordshire, UK) and sections were protected from light and incubated at RT with agitation for 2 h. Sections were incubated with the nucleus DNA stain 4′,6‐diamidino‐2‐phenylindole (DAPI) (1 μg/ml D9542‐10MG, Merck Life Science UK Ltd, Gillingham, Dorset, UK) in 1× PBS at RT with agitation for 5 min, then washed. Sections were mounted in a counterbalanced manner, coverslipped with 20 μl Mowiol® 4–88 (Merck Life Science UK Ltd, Gillingham, Dorset, UK) and stored at 4°C.

Imaging

M1 was imaged as a Z stack using a Zeiss LSM 900 confocal microscope running ZEN 2 (blue) software at 20× magnification and analysis was conducted in Fiji (1.52 g, https://imagej.nih.gov/). Exposure time was constant between sections. The average intensity projection was analysed, taken from the central focal plane and 2 adjacent focal planes in either direction, with an interplane interval of 1 μm. The area of M1 was measured using the freehand tool and cFos+ cells were manually counted. The average number of cFos+ cells/mm2 per mouse was calculated by dividing the mean number of counted cells by the area measured. Per animal 10–12 sections were counted.

Statistical analysis

Data was analysed using SPSS 23 (IBM Corporation, New York, USA), with an alpha level of p < 0.05 was regarded as significant throughout. All data was tested for normality using the Shapiro‐Wilks test. Outliers were determined by both visual inspection of boxplots and/or standardised residuals of > ± 3 (https://statistics.laerd.com/). Unless otherwise stated analysis was conducted on untransformed data. Data was analysed by unpaired two‐tailed t‐test, Mann–Whitney U, one‐way‐ANOVA, or mixed ANOVA. For t‐tests that violate homogeneity of variances, Welch's t test is used. For ANOVA where Mauchly's assumption of sphericity was violated, the Greenhouse–Geisser correction was used. The assumptions of homogeneity of variances and covariances were assessed using Levene's and Box's M tests. Significant interactions were investigated with one‐way ANOVAs.

RESULTS

There was a significant reduction in Dlg2 mRNA in the cortex of heterozygotic mice

There was no difference in the expression of Dlg2 in the cerebellum (t [9.301] = 0.547, p = 0.597, t‐test) or hippocampus, (t (21) = − 0.238, p = 0.815, t‐test) between WT and Dlg2 mice (Figure 1A,B). However, there was a reduction in mRNA in the cortex in the Dlg2 mice (t (15) = −4.163, p = 0.001, t‐test, Figure 1C). The expression of Dlg1, Dlg3, or Dlg4 in the same brain regions was not altered in the Dlg2 mice (Figure S1).
FIGURE 1

Region selective reduction in Dlg2 expression in Dlg2 mice. No changes in the expression of Dlg2 mRNA in the cerebellum (A) or hippocampus (B) of Dlg2 (HET) mice compared to WT were measured by RT‐qPCR, however there was a reduction in the cortex (prefrontal cortex) (C). Error bars represent SEM. n = Cerebellum; 9 (WT), 8 (HET), hippocampus; 12 (WT), 11 (HET), and cortex: 8 (WT), 9 (HET). ***p < 0.001 (t‐test)

Region selective reduction in Dlg2 expression in Dlg2 mice. No changes in the expression of Dlg2 mRNA in the cerebellum (A) or hippocampus (B) of Dlg2 (HET) mice compared to WT were measured by RT‐qPCR, however there was a reduction in the cortex (prefrontal cortex) (C). Error bars represent SEM. n = Cerebellum; 9 (WT), 8 (HET), hippocampus; 12 (WT), 11 (HET), and cortex: 8 (WT), 9 (HET). ***p < 0.001 (t‐test)

Dlg2 mice exhibit impaired reactivity to an acoustic stimulus but intact PPI

The average of the first three acoustic stimulus pulses at 120 dB were analysed as an index of emotional reactivity. Dlg2 mice exhibited a reduced reactivity to the 120 dB auditory stimulus (t (40) = 3.303, p = 0.004, t‐test) (Figure 2A). The reduced startle response in the Dlg2 mice to the stimulus persisted across the first 6 pulse alone trials with no evidence of habituation (TRIAL: F (3.825, 152,983) = 0.803, p = 0.520, GENOTYPE: F (1, 40) = 7.441, p = 0.009, GENOTYPE x TRIAL: F (3.825, 152.983) = 1.250, p = 0.293, mixed ANOVA) (Figure 2B).
FIGURE 2

Reduced acoustic startle responses but intact PPI of acoustic startle in Dlg2 mice. (A) Dlg2 mice (HET) showed reduced emotional reactivity compared to WT as measured as the averaged startle response to the first three startle stimuli at 120 dB. (B) The difference in startle responses between the genotypes persisted across the first 6 pulses at 120 dB. (C) There was a monotonic reduction of the startle response by an increasing intensity prepulse stimulus 40 ms before the 120 dB startle stimulus in both WT and HET mice. This occurred despite a reduced startle response in the HETs without a pre‐pulse (P120). (D) Both HET and WT mice exhibit a similar increase in startle response inhibition (% PPI) with pre‐pulse intensity when expressed as a percentage of the 120 dB pulse‐alone (P120). PP4P120, PP8P120, and PP16P120 = pre‐pulse 4 dB, 8 dB and 16 dB above background noise (70 dB), respectively. Error bars are SEM. n = 25 (WT) 17 (HET). HET compared to WT, *p < 0.05 (ANOVA), **p < 0.01 (t‐test (A), ANOVA (B) and (C))

Reduced acoustic startle responses but intact PPI of acoustic startle in Dlg2 mice. (A) Dlg2 mice (HET) showed reduced emotional reactivity compared to WT as measured as the averaged startle response to the first three startle stimuli at 120 dB. (B) The difference in startle responses between the genotypes persisted across the first 6 pulses at 120 dB. (C) There was a monotonic reduction of the startle response by an increasing intensity prepulse stimulus 40 ms before the 120 dB startle stimulus in both WT and HET mice. This occurred despite a reduced startle response in the HETs without a pre‐pulse (P120). (D) Both HET and WT mice exhibit a similar increase in startle response inhibition (% PPI) with pre‐pulse intensity when expressed as a percentage of the 120 dB pulse‐alone (P120). PP4P120, PP8P120, and PP16P120 = pre‐pulse 4 dB, 8 dB and 16 dB above background noise (70 dB), respectively. Error bars are SEM. n = 25 (WT) 17 (HET). HET compared to WT, *p < 0.05 (ANOVA), **p < 0.01 (t‐test (A), ANOVA (B) and (C)) For PPI, as the intensity of the preceding pre‐pulse increased the startle response decreased in both WT and Dlg2 but with an apparent difference between the genotypes (PULSE: F (1.742, 69.692) = 5.791, p = 0.007, GENOTYPE: F (1, 40) = 5.916, p = 0.020, PULSE × GENOTYPE: F (1.742, 69.692) = 5.791, p = 0.007, mixed ANOVA) (Figure 2C). The reduced responses in the Dlg2 mice to the startle stimulus alone (P120) are likely to confound interpretation. When startle response was adjusted for the baseline response at 120 dB, there was no difference in the percentage PPI between the genotypes over the range of pre‐pulse intensities tested (GENOTYPE: F (1, 40) = 1.704, p = 0.199, PULSE: F (1.730, 69.199) = 123.350, p = <0.01, GENOTYPE x PULSE: F (1.730, 69.199) = 0.238, p = 0.757, mixed ANOVA) (Figure 2D). By using a lower intensity startle stimulus to ameliorate a potential confound of PPI measurement by the responses to the standard 120 dB acoustic startle stimulus in the mutant animals, we showed that both genotypes showing similar emotional reactivity and PPI to a 105 dB stimulus (Figure S2). This suggests that failure to see an effect on absolute PPI in the Dlg2 mice is not likely due to a ceiling or floor response effect masking modulation of startle responses. Thus, while the startle response to a loud acoustic stimuli in the Dlg2 mice was reduced at least for a 120 dB startle stimulus, sensorimotor gating was intact in Dlg2 mice.

Dlg2 mice demonstrate impaired between‐session habituation to a novel context

The daily total beam breaks for locomotor activity sessions to an initially novel open field (novel on Day 1) were compared between the genotypes using mixed ANOVA with the following factors: Genotype (WT and HET) and Day (1–5). Both genotypes exhibited reduced activity between sessions (DAY: F (4, 132) = 31.229, p = <0.001, GENOTYPE: F (1, 33) = 0.229, p = 0.636, DAY X GENOTYPE: F (4, 132) = 2.264, p = 0.066) (Figure 3A).
FIGURE 3

Impairment in the habituation to a novel context by Dlg2 mice. (A) Both WT and Dlg2 mice (HET) mice showed a similar decrease in total beam breaks for locomotor activity conducted in an activity box measured across 5 consecutive days. (B) When the change in activity between Day 1 and Day 5 was calculated (Day 5/[Day1 + Day 5]), Dlg2 mice exhibited less change compared to WT mice, indicating weaker between‐session habituation to the context after 5 days. Error bars are SEM. n = 18 (WT), 17 (HET). **p = 0.01 (t‐test)

Impairment in the habituation to a novel context by Dlg2 mice. (A) Both WT and Dlg2 mice (HET) mice showed a similar decrease in total beam breaks for locomotor activity conducted in an activity box measured across 5 consecutive days. (B) When the change in activity between Day 1 and Day 5 was calculated (Day 5/[Day1 + Day 5]), Dlg2 mice exhibited less change compared to WT mice, indicating weaker between‐session habituation to the context after 5 days. Error bars are SEM. n = 18 (WT), 17 (HET). **p = 0.01 (t‐test) The ratio of activity measured on Day 1 and Day 5 was calculated as a measure of between‐session habituation. Both WT (t (17) = 10.967, p = 0.001, t‐test) and Dlg2 (t (15 = 4.817, p = 0.001, t‐test) mice showed a decreased ratio of activity compared to chance performance (0.5) indicating between‐session habituation in both genotypes. However, Dlg2 mice demonstrated less change in activity ratio at Day 5 and thus less habituation to the context than WT mice (t (33) = −2.750, p = 0.010, t‐test) (Figure 3B). No differences were found for within‐session habituation on any day (Figure S3). Therefore, while the Dlg2 mice appeared to show normal within‐session habituation and memory of the context exposure, they showed weaker habituation after 5 days.

Dlg2 mice displayed impaired motor learning on two accelerating rotarod protocols

In an initial experiment (Cohort 1), motor learning and function (performance) were measured using an accelerating (Days 1 and 2) and fixed speed rotarod task (Days 3–8), respectively (Figure 4A). Dlg2 mice exhibited an impairment on the accelerating rotarod, indicating deficient motor learning (TRIAL: F (4, 168) = 35.318, p = <0.001, GENOTYPE: F (1, 42) = 1.952, p = 0.170, TRIAL x GENOTYPE: F (4, 168) = 3.598, p = 0.008, mixed ANOVA) (Figure 4B). However, motor function as assessed on a fixed speed rotarod, was intact in Dlg2 mice (TRIAL: F (5.696, 233.53) = 120.649, p = < 0.001, GENOTYPE: F (1, 41) = 0.147, p = 0.704, TRIAL x GENOTYPE: F (5.696, 233.53) = 0.631, p = 0.697, mixed ANOVA) (Figure 4C).
FIGURE 4

Dlg2 mice exhibit slower motor learning but intact normal motor function and retention of motor memory across days. (A) Schematics of two independent rotarod experiments. Cohort 1 (n = 25 (WT), 18 (HET)) were first trained and tested using an accelerating rotarod protocol (Days 1 and 2) followed by a fixed speed protocol (Days 3–8) to assess motor learning and function, respectively. Motor learning in Cohort 2 was examined across three days using an accelerating rotarod protocol with more trials per day (7 trials) then the Cohort 1. (B) Cohort 1 Dlg2 mice exhibited a shorter latency to fall than WT mice at Trial 2 only (p = 0.004) on the accelerating rotarod trials. The first 2 trials were conducted on Day 1, remaining trials on Day 2 (C). In Cohort 1, the latency to fall for both genotypes decreased as the speed increased on the fixed rotarod task (Days 3–8). (D) In Cohort 2, both genotypes (n = 14 (WT), 16 (HET)) exhibit a similar decrease in latency to fall between the last trial of Day 1 and first trial of Day 2 (Day 2, Trial 1/(Day 1, Trial 7 + Day 2, Trial 1) indicating intact consolidation of the motor learning on Day 1. (E–G) Both genotypes in Cohort 2 demonstrated an increase in the latency to fall between trials on each of the three training days ((E) Day 1, p = < 0.001; (F) Day 2, p = 0.013; (G) Day 3, p = 0.030, AVOVA). However, Dlg2 mice exhibited lower mean latencies to fall across trials than WT on all the three training days. Error bars represent SEM. **p < 0.01 (ANOVA)

Dlg2 mice exhibit slower motor learning but intact normal motor function and retention of motor memory across days. (A) Schematics of two independent rotarod experiments. Cohort 1 (n = 25 (WT), 18 (HET)) were first trained and tested using an accelerating rotarod protocol (Days 1 and 2) followed by a fixed speed protocol (Days 3–8) to assess motor learning and function, respectively. Motor learning in Cohort 2 was examined across three days using an accelerating rotarod protocol with more trials per day (7 trials) then the Cohort 1. (B) Cohort 1 Dlg2 mice exhibited a shorter latency to fall than WT mice at Trial 2 only (p = 0.004) on the accelerating rotarod trials. The first 2 trials were conducted on Day 1, remaining trials on Day 2 (C). In Cohort 1, the latency to fall for both genotypes decreased as the speed increased on the fixed rotarod task (Days 3–8). (D) In Cohort 2, both genotypes (n = 14 (WT), 16 (HET)) exhibit a similar decrease in latency to fall between the last trial of Day 1 and first trial of Day 2 (Day 2, Trial 1/(Day 1, Trial 7 + Day 2, Trial 1) indicating intact consolidation of the motor learning on Day 1. (E–G) Both genotypes in Cohort 2 demonstrated an increase in the latency to fall between trials on each of the three training days ((E) Day 1, p = < 0.001; (F) Day 2, p = 0.013; (G) Day 3, p = 0.030, AVOVA). However, Dlg2 mice exhibited lower mean latencies to fall across trials than WT on all the three training days. Error bars represent SEM. **p < 0.01 (ANOVA) To further probe a motor learning deficit a more intensive accelerating rotarod protocol was employed, which allowed for investigation of fast and slow motor learning (Buitrago et al. 2004). An independent cohort of mice (Cohort 2) was trained using an accelerating rotarod task consisting of 7 trials/day for 3 consecutive days (Figure 4A). A TRIAL (F (6, 168) = 16.713, p = <0.001, mixed ANOVA), DAY (F (1.594, 44.630) = 147.891, p = <0.001, mixed ANOVA), DAY X TRIAL (F (6.664, 186.591) = 7.255, p = <0.001, mixed ANOVA) interaction, but no DAY or TRIAL X GENOTYPE interactions (DAY X GENOTYPE: F (1.594, 44.630) = 0.437, p = 0.604, TRIAL X GENOTYPE: F (6, 168) = 0.711, p 0.626, p = <0.001, DAY X TRIAL X GENOTYPE: F (6.664, 186.591) = 0.968, p = 0.454, mixed ANOVA) show that all mice show motor learning over the task (Figure 4E–G). Nevertheless, a GENOTYPE effect (F (1, 28) = 12.059, p = 0.002, mixed ANOVA) and consistently lower latencies to fall measured in the Dlg2 mice versus WT indicate weaker motor learning in heterozygous mice. In each genotype motor performance on the last trial of Day 1 was retained on the first trial of Day 2 irrespective of performance (WT: t (13) = −0.024, p = 0.981, Dlg2 : t (15) = 1.414, p = 0.178, t‐test), demonstrating that the consolidation of motor learning was unimpaired in Dlg2 mice (t (28) = −1.146, p = 0.261, t‐test) (Figure 4D).

Dlg2 mice lack increased neuronal activity in M1 following motor learning

Using cFos expression as a proxy marker for neuronal activity, we investigated cFos levels using IHC in M1 of the motor cortex 90 min after completion of two trials of an accelerating rotarod task. The time point selected reflected the phase in training where we observed the largest differences in the latency to fall between the genotypes, and when peak activity‐dependent cFos protein expression has been reported. , M1 is a key cortical region associated with motor learning, in particular during the early phase of learning. Given the previously observed impairment in motor learning, we predicted that there would be less cFos expression as an index of reduced activity in M1 after training in the Dlg2 mice. During the motor skill learning task (Figure 5A), an increased latency to fall at Trial 2 compared to Trial 1 was observed (TRIAL: F (1, 13) 6.602, p = 0.023, mixed ANOVA), but with no effect of GENOTYPE (F (1, 13) = 0.215, p = 0.624, mixed ANOVA) or TRIAL X GENOTYPE interaction (F (1, 13) = 1.602, p = 0.228, mixed ANOVA) apparent in this truncated learning protocol (Figure 5B).
FIGURE 5

Reduced cFos expression after motor rod training in M1 of Dlg2 mice (A) Schematic of experimental design. Mice (ROTA) were single caged and underwent two trials on the accelerating rotarod protocol (0–50 rpm over 5 min, ITI = 5 min) then returned to cage for 1.5 h before perfusion. Control (CON) mice were single caged in the home cage for 1.5 h before perfusion. (B) Both WT and Dlg2−/− (HET) mice show an increased latency to fall (s) between the first and second trial of the accelerating rotarod task (n = 7 (WT) 8 (HET)). (C) Only WT rotarod trained mice exhibited increased cFos expression in M1 90 min compared to single caged controls (WT: p = 0.038; HET: p = 0.900). Trained WT mice expressed more cFos compared to trained Dlg2+/− (p = 0.015). (n = 4 (WT CON), 6 (WT ROTA), 3 (HET CON), 7 (HET ROTA)). (D) Representative images of M1 stained for DAPI (blue) and cFos (green puncta). Error bars are SEM. *p < 0.01 (Mann Whitney‐U). Scale bar is 50 μm

Reduced cFos expression after motor rod training in M1 of Dlg2 mice (A) Schematic of experimental design. Mice (ROTA) were single caged and underwent two trials on the accelerating rotarod protocol (0–50 rpm over 5 min, ITI = 5 min) then returned to cage for 1.5 h before perfusion. Control (CON) mice were single caged in the home cage for 1.5 h before perfusion. (B) Both WT and Dlg2−/− (HET) mice show an increased latency to fall (s) between the first and second trial of the accelerating rotarod task (n = 7 (WT) 8 (HET)). (C) Only WT rotarod trained mice exhibited increased cFos expression in M1 90 min compared to single caged controls (WT: p = 0.038; HET: p = 0.900). Trained WT mice expressed more cFos compared to trained Dlg2+/− (p = 0.015). (n = 4 (WT CON), 6 (WT ROTA), 3 (HET CON), 7 (HET ROTA)). (D) Representative images of M1 stained for DAPI (blue) and cFos (green puncta). Error bars are SEM. *p < 0.01 (Mann Whitney‐U). Scale bar is 50 μm There was no difference in the number of cFos positive neurons in M1 in behaviourally naïve home cage control WT or Dlg2 mice (U = 3.000, p = 0.700, Mann Whitney‐U test). The number of cFos positive neurons in M1 was increased in WT mice compared to home‐cage naïve controls 90 minutes after Trial 2 (U = 12.000, p = 0.038, Mann Whitney‐U test). No increase was observed in similarly trained mice Dlg2 mice compared to home cage, Dlg2 control mice (U = 38.000, p = 0.900, Mann Whitney‐U test) (Figure 5C,D). Therefore, while both genotypes show evidence of motor learning on the accelerating rotarod between Trials 1 and 2, an increase in cFos expression in M1 motor cortex was seen in the trained WT but not Dlg2 mice as predicted.

DISCUSSION

We report that in a mouse model of Dlg2 heterozygosity, of high clinical relevance to psychiatric and developmental disorders, , reduced expression of Dlg2, but not other Dlg family members, was observed in the cortex but not hippocampus or cerebellum. The model also exhibited impairments in motor learning and long‐term habituation to a novel context, but not PPI of acoustic startle. The behavioural impairments were unconfounded by changes in anxiety as measured on the elevated plus maze or open field (Figure S4). The impact of reduced genetic dosage on specific behaviours may reflect regional haploinsufficiency and thus localised reductions in function as evidenced by the reduced activity‐dependent cFos expression in M1 motor cortex during motor learning. These impairments implicate Dlg2 in phenotypes associated with psychiatric and developmental disorders. , , , , , , , , , An impairment in motor skill learning but not motor co‐ordination in Dlg2 mice was shown in independent cohorts using two different rotarod training protocols. Using a sparse training protocol consisting of short training trials on an accelerating rotarod spread over 2 days, the Dlg2 mice showed a markedly lower improvement in performance between the first two trials on Day 1 as shown by a smaller increase in the latency to fall compared to WT. In WT, the greatest improvement in performance is seen between trials 1 and 2 on Day 1 and is consistent with the typical pattern seen with learning. Nevertheless the performance of the heterozygous mutants matched those in WT during subsequent trials on Day 2. The similarity in performance by the end of training and a formal assessment of motor function on the fixed speed rotarod after motor skill acquisition show that motor function in the Dlg2 mice was unaffected per se, and that the motor learning deficit observed was not confounded by basic deficits in motor function. The pattern of deficit in the period of rapid learning observed on the first day, equating with within‐session training, reflects an impact of Dlg2 heterozygosity on the “fast” phase of motor skill learning. , , Smaller performance improvements seen in the Dlg2 mice in early trials might also be explained by changes including altered attention, motivation or physiological “warm up” effects that are more specifically associated with within‐session. , , , However, using a more prolonged motor learning protocol (7 trials/day for 3 days) to better observe learning and memory function, Dlg2 mice similarly showed deficits in early within‐session learning. But they also showed a performance deficit that persisted across at least 3 days of training. The mutants showed retention of performance gains between the last trial on Day 1 and the first on Day 2 indicating that between‐session consolidation of motor skill memory was intact in the Dlg2 mice. Thus overall, Dlg2 mice show deficits in both “fast” within‐session and “slow” between–session motor skill learning, but intact motor function and memory consolidation. The within‐session motor learning was associated with an increase in cFos expression in M1 motor cortex in WT mice. The expression of cFos is commonly used as molecular marker of synaptic plasticity and learning. , , , The observed increase in expression demonstrates the activation M1 by the rotarod protocols we employed, which is consistent with the critical contribution of M1 to fast motor skill learning in rodents and to fast and slow motor skill learning in both rodents and humans. The failure to see a similar increase in cFos expression in the Dlg2 mice correlates with their impairment in motor learning and implicate DLG2‐associated plasticity mechanisms, particularly LTP to support motor learning. An alternative explanation that the large difference in cortical cFos expression between the genotypes simply relates to locomotor activity is less likely because both groups show low levels of motor activity (i.e., low latencies to quit the rotating rod) at this non‐asymptotic point in early training. While the plasticity processes in motor cortex are associated with fast and slow learning, the loci and the contributing circuits, including subcortical structures, are distinct , , and likely involve the selective engagement of neuronal subtypes or clusters. Furthermore, the activated networks that represent the motor memory “engram” continue to be refined through both within‐ and between‐session motor skill learning. The deficits in both fast and slow motor skill learning in the Dlg2 mice are consistent with a broad role for DLG2 in motor leaning‐associated plasticity processes in M1 (this study) and associated circuits more widely. While the discrepancy we see in our two learning experiments regarding between‐session learning, with Dlg2 mice showing persistently lower performance between sessions only when trained using longer sessions over several days, cannot be explained by a difference in the task used (they are the same), it is possible that prolonged training engages different circuits such as cortico‐striatal pathways involved in developing habitual responses. We speculate that these circuits may also be more sensitive to the reduced DLG2 dosage in this heterozygous mouse model. Deficits in between‐session habituation to a novel context in the Dlg2 mice manifested as a smaller decrease in locomotor activity after five consecutive days than WT. Repeated exposure to an unfamiliar stimulus, such as a context, results in reduced responses, including locomotor activity, over time as the stimulus becomes less novel. , Nevertheless, within‐session habituation was similar in both genotypes, perhaps reflecting a greater impact of DLG2 heterozygosity on long‐term than short‐term habituation and the different molecular and plasticity mechanisms supporting them. Notably long‐term habituation requires protein synthesis for its production and maintenance , similar to NMDA receptor‐mediated plasticity mechanisms regulating long‐term associative memory. Interestingly, habituation impairments have been reported in Gria1 knockout mice. The authors proposed that deficits in habituation are central to psychological processes such as sensitization and aberrant salience that give rise to psychosis associated with SZ and other psychiatric conditions. Together with our data, this suggests disruptions that AMPAR‐mediated signalling involving DLG2 at glutamatergic synapses is a mechanism underlying behavioural habituation deficits that are core for psychosis. To our knowledge this was the first study investigating acoustic startle and PPI in Dlg2 mutants. PPI deficits are a common feature of a range of neuropsychiatric disorders serving as an endophenotype to identify risk genes in humans and to illuminate neural processes and circuits affected in genetic models in animals. The Dlg2 mice show no impairment in PPI. A decrease in reactivity to the standard 120 dB startle stimulus in the mutants is unlikely to account for the inability to detect a change in PPI because PPI was similarly unaffected using a 105 dB intensity startle stimulus where reactivity in the two genotypes was matched. The decreased startle reactivity is unlikely to be due to a gross motor deficit as motor co‐ordination and initial locomotor activity an open field were unaffected in the Dlg2 mice. Thus, whilst an explanation regarding the impaired ASRs needs to be elucidated, reduced dosage of Dlg2 does not appear to affect sensorimotor gating in this mouse model. Our observations of unaffected motor performance and locomotor activity in the Dlg2 mice can be viewed as broadly concordant with previous investigations using DLG2 models when considering gene dosage. Motor coordination and performance in the exon 6 Dlg2 deletion model has been reported to be either unaffected or mildly impaired, but with the impairment absent was in the heterozygous mice. Both Dlg2 (exon 6) and Dlg2 Δ14/Δ14 (the same exon targeted as in the mice used in our study) deletion models show mild hypoactivity activity in novel open fields but not in familiar environments. Together the data suggest that while subtle effects can be seen on motor function‐related behaviours in deletion models, these deficits are absent when one copy of Dlg2 is present. The dosage effect may highlight a role for DLG2 in locomotor‐related behaviour, including locomotor behaviours associated with novelty detection, but the role is redundant because DLG paralogs are able to compensate for a reduction of DLG2 function. This hypothesis may equally apply to another behavioural phenotype observed in genetic DLG2 models, that of altered social behaviours which is seen in DLG homozygotes , but not heterozygotes. Thus, the utility of heterozygous models is not only in interrogating more accurate genetic risk models for human disease but also for identifying the essential, or selective functions, associated with the targeted gene. Additionally, it is important to note that we measured reduced expression of DLG2 in some brain regions (cortical) but not others (hippocampus and cerebellum). A differential impact on regional expression levels if recapitulated more widely, and are reflected at the functional protein level, may be another source of specificity and variability in observed functional deficits within and between genetic models. The selectively of the impairments we see in Dlg2 mice may reflect the impact of DLG haploinsufficiency on long‐term synaptic plasticity mechanisms within functional circuitries. Deficits in long‐term motor learning and habitation may be indicative of impairments in synaptic plasticity mechanisms in the cortico‐striato‐thalamo‐cortical and cortico‐cerebello‐ thalamo‐cortico pathways underlying motor learning (as discussed earlier), and the medial temporal‐midbrain‐striatal pathways that mediate the novelty‐to‐familiarly transition of stimuli that manifest as habituation. DLG2 is critical for LTP, which underlies long‐term protein‐synthesis dependent learning, but not AMPA and NMDA receptor–mediated synaptic transmission that are extant for information processing and behavioural responses not dependent on LTP such as motor co‐ordination, PPI, and anxiety. In comparison to DLG2 mutants, DLG4 (PSD‐95) models show alterations in both glutamatergic long‐term plasticity and basal transmission and also more severe and wider ranging behavioural affects. These observations lend further support for a role for DLG2 in functions specifically dependent on long‐term plasticity. It is being established that the multiple paralogs of DLG2 have differential roles in regulating synaptic function. , Understanding the precise contribution of individual DLG2 variants to functional outputs will be an important goal for future studies and will help us understand the subtly and selectivity of the impact of specific DLG2 mutations on brain development, behaviour and function.

CONCLUSIONS

In this paper, we present data indicating heterozygosity of Dlg2, which has been previously associated with a number of psychiatric diseases, results in selective behavioural deficits similarly associated with disease in Dlg2 mice. The deficits in motor learning and long‐term habituation of locomotor responses to a novel context that we observed in the mutant mice can broadly be considered as failures to adapt to the environment. These are also functions dependent on synaptic plasticity mechanisms, which DLG2 mediates. The reduced cortical regulation of the plasticity‐associated gene cFos during motor learning may indeed be a molecular signature for impairments in synaptic plasticity in DLG2 mutant models. Other functions including sensorimotor gating of an acoustic stimulus measured by PPI, motor co‐ordination and anxiety were unaffected in this Dlg2 mouse model. This suggests functional behavioural and cognitive domains associated with long‐term adaptation to the environment that also depend on specific long‐term plasticity mechanisms are particularly sensitive to haploinsufficiency of DLG2 across psychiatric disorders. Data S1. Supporting information. Click here for additional data file.
  81 in total

Review 1.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

2.  Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.

Authors:  Guillermo M Elias; Lars Funke; Valentin Stein; Seth G Grant; David S Bredt; Roger A Nicoll
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

3.  Differential corticostriatal plasticity during fast and slow motor skill learning in mice.

Authors:  Rui M Costa; Dana Cohen; Miguel A L Nicolelis
Journal:  Curr Biol       Date:  2004-07-13       Impact factor: 10.834

4.  Assessment of murine startle reactivity, prepulse inhibition, and habituation.

Authors:  Mark A Geyer; Stephanie C Dulawa
Journal:  Curr Protoc Neurosci       Date:  2003-11

5.  Identification of risk genes for autism spectrum disorder through copy number variation analysis in Austrian families.

Authors:  Gerald Egger; Katharina M Roetzer; Abdul Noor; Anath C Lionel; Huda Mahmood; Thomas Schwarzbraun; Oliver Boright; Anna Mikhailov; Christian R Marshall; Christian Windpassinger; Erwin Petek; Stephen W Scherer; Wolfgang Kaschnitz; John B Vincent
Journal:  Neurogenetics       Date:  2014-03-19       Impact factor: 2.660

Review 6.  The synapse in schizophrenia.

Authors:  Andrew J Pocklington; Michael O'Donovan; Michael J Owen
Journal:  Eur J Neurosci       Date:  2014-04       Impact factor: 3.386

7.  Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.

Authors:  Antonio F Pardiñas; Peter Holmans; Andrew J Pocklington; Valentina Escott-Price; Stephan Ripke; Noa Carrera; Sophie E Legge; Sophie Bishop; Darren Cameron; Marian L Hamshere; Jun Han; Leon Hubbard; Amy Lynham; Kiran Mantripragada; Elliott Rees; James H MacCabe; Steven A McCarroll; Bernhard T Baune; Gerome Breen; Enda M Byrne; Udo Dannlowski; Thalia C Eley; Caroline Hayward; Nicholas G Martin; Andrew M McIntosh; Robert Plomin; David J Porteous; Naomi R Wray; Armando Caballero; Daniel H Geschwind; Laura M Huckins; Douglas M Ruderfer; Enrique Santiago; Pamela Sklar; Eli A Stahl; Hyejung Won; Esben Agerbo; Thomas D Als; Ole A Andreassen; Marie Bækvad-Hansen; Preben Bo Mortensen; Carsten Bøcker Pedersen; Anders D Børglum; Jonas Bybjerg-Grauholm; Srdjan Djurovic; Naser Durmishi; Marianne Giørtz Pedersen; Vera Golimbet; Jakob Grove; David M Hougaard; Manuel Mattheisen; Espen Molden; Ole Mors; Merete Nordentoft; Milica Pejovic-Milovancevic; Engilbert Sigurdsson; Teimuraz Silagadze; Christine Søholm Hansen; Kari Stefansson; Hreinn Stefansson; Stacy Steinberg; Sarah Tosato; Thomas Werge; David A Collier; Dan Rujescu; George Kirov; Michael J Owen; Michael C O'Donovan; James T R Walters
Journal:  Nat Genet       Date:  2018-02-26       Impact factor: 38.330

8.  Synaptic scaffold evolution generated components of vertebrate cognitive complexity.

Authors:  Jess Nithianantharajah; Noboru H Komiyama; Andrew McKechanie; Mandy Johnstone; Douglas H Blackwood; David St Clair; Richard D Emes; Louie N van de Lagemaat; Lisa M Saksida; Timothy J Bussey; Seth G N Grant
Journal:  Nat Neurosci       Date:  2012-12-02       Impact factor: 24.884

9.  Prepulse inhibition of the acoustic startle reflex in high functioning autism.

Authors:  Sina Kohl; Carolin Wolters; Theo O J Gruendler; Kai Vogeley; Joachim Klosterkötter; Jens Kuhn
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

Review 10.  Genomic insights into the overlap between psychiatric disorders: implications for research and clinical practice.

Authors:  Joanne L Doherty; Michael J Owen
Journal:  Genome Med       Date:  2014-04-28       Impact factor: 11.117

View more
  4 in total

1.  Enhancing DLG2 Implications in Neuropsychiatric Disorders: Analysis of a Cohort of Eight Patients with 11q14.1 Imbalances.

Authors:  Veronica Bertini; Roberta Milone; Paola Cristofani; Francesca Cambi; Chiara Bosetti; Filippo Barbieri; Silvano Bertelloni; Giovanni Cioni; Angelo Valetto; Roberta Battini
Journal:  Genes (Basel)       Date:  2022-05-12       Impact factor: 4.141

2.  Behavioural and molecular characterisation of the Dlg2 haploinsufficiency rat model of genetic risk for psychiatric disorder.

Authors:  Sophie Waldron; Rachel Pass; Simonas Griesius; Jack R Mellor; Emma S J Robinson; Kerrie L Thomas; Lawrence S Wilkinson; Trevor Humby; Jeremy Hall; Dominic M Dwyer
Journal:  Genes Brain Behav       Date:  2022-01-25       Impact factor: 3.708

3.  Pedigree-based study to identify GOLGB1 as a risk gene for bipolar disorder.

Authors:  Fa-Rong Liu; Yunqiang Zhou; Yong Wang; Ling-Ling Huang; Xian Zhang; Hong Luo; Su-Ying Wu; Hai-Yan Lyu; Li-Huan Huang; Huaxi Xu; Yun-Wu Zhang
Journal:  Transl Psychiatry       Date:  2022-09-17       Impact factor: 7.989

4.  Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2.

Authors:  Rachel Pass; Niels Haan; Trevor Humby; Lawrence S Wilkinson; Jeremy Hall; Kerrie L Thomas
Journal:  Genes Brain Behav       Date:  2022-02-03       Impact factor: 3.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.